These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 20042013)
1. Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation. Vieira TC; Bergamin CS; Gurgel LC; Moisés RS Pediatr Diabetes; 2010 Nov; 11(7):505-8. PubMed ID: 20042013 [TBL] [Abstract][Full Text] [Related]
2. [Congenital hyperinsulinism in newborn and infant]. Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924 [TBL] [Abstract][Full Text] [Related]
4. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism. Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196 [TBL] [Abstract][Full Text] [Related]
5. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures. Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell. Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858 [TBL] [Abstract][Full Text] [Related]
7. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672 [TBL] [Abstract][Full Text] [Related]
8. Seizure due to somatostatin analog discontinuation in a case diagnosed as congenital hyperinsulinism novel mutation. Baş VN; Ozkan M; Zenciroğlu A; Cavuşoğlu YH; Cetinkaya S; Aycan Z J Pediatr Endocrinol Metab; 2012; 25(5-6):553-5. PubMed ID: 22876555 [TBL] [Abstract][Full Text] [Related]
9. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Kapoor RR; Flanagan SE; James CT; McKiernan J; Thomas AM; Harmer SC; Shield JP; Tinker A; Ellard S; Hussain K Diabetologia; 2011 Oct; 54(10):2575-83. PubMed ID: 21674179 [TBL] [Abstract][Full Text] [Related]
10. A novel mutation associated with congenital hyperinsulinism. Natarajan G; Aggarwal S; Merritt TA Am J Perinatol; 2007 Aug; 24(7):401-4. PubMed ID: 17597441 [TBL] [Abstract][Full Text] [Related]
11. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks. Kumaran A; Kapoor RR; Flanagan SE; Ellard S; Hussain K Horm Res Paediatr; 2010; 73(4):287-92. PubMed ID: 20215776 [TBL] [Abstract][Full Text] [Related]
12. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy. Sandal T; Laborie LB; Brusgaard K; Eide SA; Christesen HB; Søvik O; Njølstad PR; Molven A Clin Genet; 2009 May; 75(5):440-8. PubMed ID: 19475716 [TBL] [Abstract][Full Text] [Related]
13. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia. Flanagan SE; Kapoor RR; Banerjee I; Hall C; Smith VV; Hussain K; Ellard S Clin Genet; 2011 Jun; 79(6):582-7. PubMed ID: 20573158 [TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197 [TBL] [Abstract][Full Text] [Related]
16. Congenital hyperinsulinism caused by mutations in ABCC8 (SUR1) gene. Thakur S; Flanagan SE; Ellard S; Verma IC Indian Pediatr; 2011 Sep; 48(9):733-4. PubMed ID: 21992908 [TBL] [Abstract][Full Text] [Related]
17. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. Macmullen CM; Zhou Q; Snider KE; Tewson PH; Becker SA; Aziz AR; Ganguly A; Shyng SL; Stanley CA Diabetes; 2011 Jun; 60(6):1797-804. PubMed ID: 21536946 [TBL] [Abstract][Full Text] [Related]
18. Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence. Abdulhadi-Atwan M; Bushman J; Tornovsky-Babaey S; Perry A; Abu-Libdeh A; Glaser B; Shyng SL; Zangen DH Diabetes; 2008 Jul; 57(7):1935-40. PubMed ID: 18390792 [TBL] [Abstract][Full Text] [Related]
19. KATP channel mutations in congenital hyperinsulinism. Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999 [TBL] [Abstract][Full Text] [Related]
20. Congenital Hyperinsulinism Caused by Mutations in Butnariu LI; Bizim DA; Păduraru G; Păduraru L; Moisă ȘM; Popa S; Gimiga N; Ghiga G; Bădescu MC; Lupu A; Vasiliu I; Trandafir LM Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]